Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10235187.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Smoking is protective against developing ulcerative colitis. Nicotine may be the cause of this protective effect. Controlled trials have demonstrated efficacy of transdermal nicotine for active ulcerative colitis. Side effects observed with transdermal nicotine include contact dermatitis, nausea, and lightheadedness. Topical administration of nicotine to the colon reduces nicotine blood concentrations and side effects, and may be of clinical benefit.
Medical subject headings
- Colitis, Ulcerative
- Nicotine